Skip to main content

Table 2 GO analysis of the candidate miRNAs in TRD

From: Abnormal expression profile of plasma-derived exosomal microRNAs in patients with treatment-resistant depression

Term Overlap P-values
Axon part (GO:0033267) 32/415 0.003757
CHD-type complex (GO:0090545) 4/18 0.008459
Cytoplasmic ribonucleoprotein granule (GO:0036464) 23/268 0.003642
Early endosome (GO:0005769) 34/434 0.002231
NuRD complex (GO:0016581) 4/18 0.008459
PML body (GO:0016605) 13/113 0.002301
Postsynaptic density (GO:0014069) 25/35 0.006811
Ribonucleoprotein granule (GO:0035770) 23/281 0.006435
Transcription factor complex (GO:0005667) 33/403 0.001257
Transcriptional repressor complex (GO:0017053) 11/90 0.003031
Appendage development (GO:0048736) 23/188 0.000026
Axonogenesis (GO:0007409) 46/498 0.000010
Cell fate commitment (GO:0045165) 34/304 0.000003
Embryonic organ development (GO:0048568) 43/480 0.000041
Limb development (GO:0060173) 23/188 0.000026
Lung development (GO:0030324) 23/193 0.000040
Positive regulation of neuron differentiation (GO:0045666) 41/402 0.000003
Positive regulation of neuron projection development (GO:0010976) 32/304 0.000018
Regulation of cellular component size (GO:0032535) 39/407 0.000021
Regulation of transcription involved in cell fate commitment (GO:0060850) 7/18 0.000010
DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228) 46/479 0.000009
GTP binding (GO:0005525) 33/406 0.002841
Guanyl nucleotide binding (GO:0019001) 35/429 0.002028
Guanyl ribonucleotide binding (GO:0032561) 35/429 0.002028
Nucleoside binding (GO:0001882) 33/422 0.005119
Purine nucleoside binding (GO:0001883) 33/414 0.003839
Purine ribonucleoside binding (GO:0032550) 33/411 0.003434
Ribonucleoside binding (GO:0032549) 33/415 0.003982
SUMO transferase activity (GO:0019789) 5/20 0.002265
Transcription corepressor activity (GO:0003714) 22/195 0.000214